Please use this identifier to cite or link to this item:
http://hdl.handle.net/11375/13086
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.advisor | Chan, Anthony K.C. | en_US |
dc.contributor.author | Chander, Ankush | en_US |
dc.date.accessioned | 2014-06-18T17:02:20Z | - |
dc.date.available | 2014-06-18T17:02:20Z | - |
dc.date.created | 2013-06-30 | en_US |
dc.date.issued | 2013-10 | en_US |
dc.identifier.other | opendissertations/7914 | en_US |
dc.identifier.other | 8955 | en_US |
dc.identifier.other | 4269717 | en_US |
dc.identifier.uri | http://hdl.handle.net/11375/13086 | - |
dc.description.abstract | <p>Unfractionated heparin (UFH) is used as an adjunct during thrombolytic therapy. However, its use is associated with many clinical limitations, such as the inability to inhibit fibrin-bound coagulation factors, increasing the potential for sustained procoagulant activity. We have developed a covalent conjugate of antithrombin (AT) and heparin (ATH) with superior anticoagulant properties to those of UFH. Some advantages of ATH include enhanced inhibition of surface-bound enzymes and its ability to reduce the overall size and mass of clots <em>in vivo</em>. However, the potential interactions of UFH or ATH with the components of the fibrinolytic pathway are not well understood. Therefore, our study utilized discontinuous second order rate constant (<em>k<sub>2</sub></em>) assays to determine rates of inhibition of plasmin (Pn) in the presence or absence of fibrin by AT+UFH <em>vs.</em> ATH. In addition, we monitored the rates of Pn generation in a system comprised of preformed fibrin clots with the aim of evaluating the inhibitory effect of AT+UFH or ATH in this more native system. The <em>k<sub>2 </sub></em>values for the inhibition of Pn without fibrin were 5.74x10<sup>6</sup>±0.278x10<sup>6</sup> and 6.39x10<sup>6</sup>±0.588x10<sup>6</sup> for AT+UFH and ATH, respectively (p=0.36). In the presence of fibrin, the <em>k<sub>2 </sub></em>values decreased to 1.45x10<sup>6</sup>±0.0971x10<sup>6</sup> for AT+UFH and 3.07x10<sup>6</sup>±0.192x10<sup>6 </sup>for ATH (<em>p</em></p> | en_US |
dc.subject | Heparin | en_US |
dc.subject | Fibrinolysis | en_US |
dc.subject | Plasmin | en_US |
dc.subject | Thrombosis | en_US |
dc.subject | Thrombolysis | en_US |
dc.subject | Coagulation | en_US |
dc.subject | Biochemistry | en_US |
dc.subject | Hematology | en_US |
dc.subject | Medicinal and Pharmaceutical Chemistry | en_US |
dc.subject | Biochemistry | en_US |
dc.title | Interactions of a covalently - linked antithrombin-heparin complex with components of the fibrinolytic pathway | en_US |
dc.type | thesis | en_US |
dc.contributor.department | Medical Sciences (Blood and Cardiovascular) | en_US |
dc.description.degree | Master of Science (MS) | en_US |
Appears in Collections: | Open Access Dissertations and Theses |
Files in This Item:
File | Size | Format | |
---|---|---|---|
fulltext.pdf | 664.17 kB | Adobe PDF | View/Open |
Items in MacSphere are protected by copyright, with all rights reserved, unless otherwise indicated.